Analyst firms · Morgan Stanley · ENFN

Morgan Stanley ENFN price target and rating history

Enfusion Inc. (ENFN) · Technology

Morgan Stanley rates Enfusion Inc. (ENFN) Overweight with a $11 price target, as of its latest action on May 10, 2024. It has published 4 rating actions on ENFN since November 2021, including 1 upgrade and 0 downgrades.

Current rating

Overweight

Price target

$11

Median target, all firms

Too few

Actions on ENFN

4

Morgan Stanley price target on ENFN

Every Morgan Stanley rating on ENFN

• May 10, 2024
  ResumeMorgan Stanley resumes coverage at Overweight, price target $11
• Jan 3, 2023
  UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $13 to $12
• Dec 3, 2021
  ReiterateMorgan Stanley cuts its price target to $22 from $24, keeps Equal-Weight
• Nov 15, 2021
  InitiateMorgan Stanley starts coverage at Equal-Weight, price target $24

Questions about Morgan Stanley and ENFN

What is Morgan Stanley's price target for ENFN?

Morgan Stanley's latest stated price target for Enfusion Inc. (ENFN) is $11, from its action on May 10, 2024.

What is Morgan Stanley's rating on ENFN?

Morgan Stanley rates ENFN Overweight, a bullish rating, as of May 10, 2024.

When did Morgan Stanley last change its view on ENFN?

On May 10, 2024, Morgan Stanley resumes coverage at Overweight, price target $11.

More ENFN rating histories

• BofA Securities3

All Morgan Stanley ratingsENFN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.